Highlights DexCom, Inc.

Equities

DXCM

US2521311074

Market Closed - Nasdaq Other stock markets 21:00:00 25/06/2024 BST			5-day change	1st Jan Change
110.3 ^USD	-0.24%		-5.43%	-11.10%

06-25	Out with AI, in with defensive stocks
06-20	Glucotrack Announces the Appointment of Andy Balo to Board of Directors	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Dexcom Expands Aid Partnership into the Netherlands	06-20	CI
Dexcom Showcases Extensive Clinical Data At ADA 2024 Demonstrating the Benefit of Dexcom CGM Use Among People with Type 2 Diabetes	06-20	CI
Tandem Diabetes Care, Inc. and Dexcom, Inc. Enter into Amended and Restated Development Agreement to Original Development Agreement and Amended and Restated Commercialization Agreement to Original Commercialization Agreement	06-18	CI
Dexcom, Inc. Announces the Dexcom G7 Continuous Glucose Monitoring System Now Connects Directly to Apple Watch in the United States	06-05	CI
Dexcom Wins Access to Dexcom One for 100,000 People Living with Type 2 Diabetes	06-04	CI
Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems	06-03	CI
Bio Conscious Announces Strategic Api Integration with Dexcom That Will Elevate the Current Level of Care for Diabetes Patients in Clinical Settings	05-16	CI
Glutality Powered by StrideMD Announces Integration with Dexcom to Enhance Remote Diabetes Care with CGM Technology	04-30	CI
Wall Street: the worst week of 2024 is followed by the best	04-26	CF
Dexcom's profit beats estimates on strong glucose monitor demand	04-25	RE
DexCom, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25	CI
DexCom Q1 Non-GAAP Earnings, Revenue Rise; 2024 Revenue Guidance Gains; Shares Fall After Hours	04-25	MT
Earnings Flash (DXCM) DEXCOM Posts Q1 EPS $0.32, vs. Street Est of $0.27	04-25	MT
Earnings Flash (DXCM) DEXCOM Posts Q1 Revenue $921M, vs. Street Est of $910.9M	04-25	MT
DexCom, Inc. Provides Earnings Guidance for the Year 2024	04-25	CI
MD Revolution Partners with Dexcom to Integrate Continuous Glucose Monitoring Systems with Its Remote Care Management Platform	04-10	CI
DexCom is still in the running	03-07
DexCom Shares Rise After Prescription-Free Glucose Biosensor Wins FDA Clearance	03-06	MT
US FDA clears use of first over-the-counter continuous glucose monitor	03-05	RE
DexCom Says Prescription-Free Glucose Biosensor Wins FDA Clearance	03-05	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

DexCom is still in the running

March 07, 2024 at 09:49 am